Blood test for inflammation in lupus patients
Part of Immune system & allergy, Kidney & urinary, Skin, Women’s health & pregnancy clinical trials.
This study looks at a simple blood test (called the Systemic Immune Inflammatory Index) to see if it can help doctors understand how active lupus is in your body. It includes people with lupus, especially those with kidney involvement, to find better ways to track the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 17 years or older.
- You have been diagnosed with systemic lupus erythematosus (SLE) by a doctor following official guidelines.
- If you have lupus-related kidney disease (lupus nephritis), it must have been confirmed by a kidney biopsy.
- You do not have other autoimmune diseases, cancer, liver disease, end-stage kidney disease, or active infections.
- You have not had a recent blood transfusion and do not have deficiencies in vitamin B12, folate, or iron.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether two blood test markers (called T IgG and T IgM) can help doctors understand how active your lupus is and how much damage the disease has caused. If you join, your blood will be tested, and the results may help guide your treatment.
This trial uses an ultrasound to measure kidney blood flow in people with lupus kidney disease. The goal is to see if this simple test can tell how active the disease is, which might help doctors adjust treatment without needing frequent biopsies.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.
This study looks at blood and urine markers that may show how active lupus kidney disease is and how it changes over time. It may help doctors better monitor people with active lupus-related kidney inflammation.
This study looks at whether a blood test for a specific antibody can help doctors understand how active lupus kidney disease is. It may help guide treatment decisions for people with lupus nephritis.
Hear when a new Systemic Lupus Erythematosus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.